<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">Familial adenomatous polyposis</z:e> (FAP) is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> predisposition syndrome that accounts for approximately 0.5-1% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cases </plain></SENT>
<SENT sid="1" pm="."><plain>It is caused by germline mutations in the gene encoding the <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor </plain></SENT>
<SENT sid="2" pm="."><plain>Somatic APC inactivation due to mutation or loss of heterozygosity (LOH) promotes the development of <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath> by stabilizing the transcriptional coactivator β-catenin </plain></SENT>
<SENT sid="3" pm="."><plain>Although <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is by far the most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> seen in FAP patients, the widespread use of prophylactic colectomy in these patients has increased the clinical importance of extracolonic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> that are part of the neoplastic spectrum in FAP </plain></SENT>
<SENT sid="4" pm="."><plain>Many of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> exhibit LOH or somatic APC mutation, strongly supporting a causative role of APC inactivation in their pathogenesis </plain></SENT>
<SENT sid="5" pm="."><plain>Here we describe a 47-year-old female FAP patient with clinical manifestations of virilization who was found to have an <z:e sem="disease" ids="C1518740,C0334412" disease_type="Neoplastic Process" abbrv="">ovarian steroid cell tumor</z:e>, a rare <z:hpo ids='HP_0002664'>neoplasm</z:hpo> not known to be associated with FAP </plain></SENT>
<SENT sid="6" pm="."><plain>Immunohistochemical analysis of the <z:mp ids='MP_0008000'>ovarian tumor</z:mp> demonstrated strong nuclear β-catenin staining consistent with somatic APC inactivation, and molecular analysis confirmed biallelic APC inactivation in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings provide the first evidence that <z:e sem="disease" ids="C1518740,C0334412" disease_type="Neoplastic Process" abbrv="">ovarian steroid cell tumors</z:e> may be an extracolonic manifestation of FAP and implicate β-catenin activation as an oncogenic mechanism in ovarian steroid cell <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>